Pomerantz LLP Appointed Lead Counsel in Endo International plc Securities Litigation

On September 29, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Endo International plc, regarding allegations that the company concealed its known adverse contribution to the U.S. opioid crisis, particularly the company’s products’ disproportionate impact on New York State, and lied to health care providers about the known risks of opioids.